Mitochondrial diseases

Clinical trial ongoing at the Institute:

  • Prospective follow-up of a cohort of patients with mitochondrial diseases
  • REN001-201 / STRIDE: A double-blind, placebo-controlled study to evaluate the efficacy and safety of 24 weeks treatment with REN001 in patients with primary mitochondrialmyopathy (PMM)



Prospective follow-up

REN001-201 / STRIDE

Intervention REN001
Principal investigators
Pascal Laforêt Tanya Stojkovic
Sponsor AIM Reneo Pharma Ltd.
Study status Ongoing In preparation
Recruitment status Ongoing In preparation
Population Adult Adult
  + infos on clinical